May 2017 Issue of MMM
Researchers still don't know why Americans who are prescribed a prescription drug to treat a chronic condition or disease so often fail to fill those ...
Healthcare's collision with lower-cost genetic sequencing, mobile tech, AI, and consumerization will transform the trajectory of how we live for the next 10 years.
Here you'll find Sara Holoubek's deep dive into how pharma is tackling some of its biggest challenges.
Here you'll find everything from our May 2017 issue, including our Top 40 Transformers, deep dive into autoimmune drugs, and more.
MM&M honors 40 upstarts and veteran innovation gurus.
For the first time MM&M honors a group of 10 agency execs.
Under Duato, the leadership team for Johnson & Johnson's pharma group includes six women. "We don't just talk about it," he says.
Agency vets Nadine Leonard and James Talerico to co-lead Publicis-owned shop.
AbbVie's Humira tops the list, according to data compiled by EvaluatePharma.
While investments in investigational lupus agents appear to be heating up, late-stage clinical failure continues to be a major hurdle to market entry.
Makers of biosimilars have targeted a few of the top-selling autoimmune drugs. Get ready for some of the highest-stakes pricing and access skirmishes in recent ...
This and other changes in the market have created demand for new offerings, like mobile-friendly sites, video, and patient communities.
How can agencies best entice clients to incorporate behavioral science into their marketing programs?
In short, he'll be further along the learning curve than anyone ever tapped for the nation's number-one public health regulatory slot.
The chief creative officer takes a look at campaigns in and outside the U.S.
At Work With
He instead decided to find a way to make a physician's job easier by creating a clinical messaging platform.
Perhaps we should always bear in mind the need to periodically reinvigorate and reshape our careers.